ACET Adicet Bio, Inc.

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cells therapies for cancer and other diseases.

$13.86  -0.50 (-3.48%)
As of 06/28/2022 14:43:46 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/26/2018
Outstanding shares:  40,004,357
Average volume:  1,003,213
Market cap:   $545,259,386
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMC5RV6
Valuation   (See tab for details)
PE ratio:   -15.12
PB ratio:   1.75
PS ratio:   13.89
Return on equity:   -11.59%
Net income %:   -91.87%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy